BIOTIDE LIMITED

Dissolved Saffron Walden

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
B

BIOTIDE LIMITED

Research and experimental development on biotechnology

Founded 13 Feb 2020 Dissolved Saffron Walden, England 0 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 24 Oct 2024
Confirmation Submitted 12 Feb 2024 Next due 26 Feb 2025 16 months overdue
Net assets £1 £0 2023 year on year
Total assets £1 £0 2023 year on year
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

Newnham Building Chesterford Park Little Chesterford Saffron Walden CB10 1XL England

Full company profile for BIOTIDE LIMITED (12461717), a dissolved company based in Saffron Walden, England. Incorporated 13 Feb 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Mar → 29 Feb 2024
Type dormant
Next accounts
Due by

Net Assets, Total Assets & Total Liabilities (2020–2023)

Cash in Bank

N/A

Net Assets

£1.00

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
29 Feb Year End
2023
28 Feb Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active
Status
Matthew Alan GregoryDirectorBritishUnited Kingdom5013 Feb 2020Active
Steven James MossDirectorBritishEngland5213 Feb 2020Active

Shareholders

Shareholders (1)

Isomerase Therapeutics Limited
100.0%

Persons with Significant Control

Persons with Significant Control (3)

3 Active

Matthew Alan Gregory

British

Active
Notified 13 Feb 2020
Residence United Kingdom
DOB July 1975
Nature of Control
  • Voting Rights 25 To 50 Percent,right To Appoint And Remove Directors
Active
Notified 13 Feb 2020
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Steven James Moss

British

Active
Notified 13 Feb 2020
Residence England
DOB April 1974
Nature of Control
  • Voting Rights 25 To 50 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

BIOTIDE LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
29 Apr 2025GazetteGazette Dissolved Voluntary
14 Mar 2025DissolutionDissolution Voluntary Strike Off Suspended
11 Feb 2025GazetteGazette Notice Voluntary
4 Feb 2025DissolutionDissolution Application Strike Off Company
24 Oct 2024AccountsAnnual accounts made up to 29 Feb 2024
29 Apr 2025 Gazette

Gazette Dissolved Voluntary

14 Mar 2025 Dissolution

Dissolution Voluntary Strike Off Suspended

11 Feb 2025 Gazette

Gazette Notice Voluntary

4 Feb 2025 Dissolution

Dissolution Application Strike Off Company

24 Oct 2024 Accounts

Annual accounts made up to 29 Feb 2024

Recent Activity

Latest Activity

Gazette Dissolved Voluntary

1 years ago on 29 Apr 2025

Dissolution Voluntary Strike Off Suspended

1 years ago on 14 Mar 2025

Gazette Notice Voluntary

1 years ago on 11 Feb 2025

Dissolution Application Strike Off Company

1 years ago on 4 Feb 2025

Annual accounts made up to 29 Feb 2024

1 years ago on 24 Oct 2024